Illumina Ventures’ Post

Read this nice blog from the Oncode Accelerator team on the network of the Federation of European Biochemical Societies (FEBS), with more detail on the Innovation Platforms and Workstreams within the program and our call for Demonstrator Projects. #FEBS #cancerresearch #drugdevelopment #oncodeaccelerator #biotech

✨Introducing TAmiRNA´s small RNA-sequencing-based molecular characterization of EVs. Since we launched the revolutionary EVscale™️ - Extracellular Vesicles at scale – platform, which was developed in partnership between Phoenestra GmbH, Evercyte GmbH, and TAmiRNA GmbH, we are highlighting key components and features of this platform in a series of posts, explaining how this cutting-edge platform is transforming the way EV therapeutics are produced: TAmiRNA is an expert in RNA biomarker discovery and validation. Under the lead of Kseniya Khamina-Kotisch, PhD and Andreas Diendorfer it has developed a small RNA-seq workflow for absolute quantification of microRNAs that are carried by EVs. The platform, which is called miND®, is a game changer in the identification of the molecular constituents of EVs and understanding on therapeutic potency of these complex products. By combining miRNomics with transcriptomic and proteomic analyses, TAmiRNA supports EVscale™ by decoding the molecular signature of EVs and identifying key cargo that can be utilized for the quality control as well as for further engineering of EV potency. Browse TAmiRNA´s offerings for EV characterization at https://lnkd.in/dTAfRmvi   🚀 Stay tuned for further posts on our transformative journey towards scalable and efficient EV production for therapeutic purposes. #ExtracellularVesicles #EVscale #microRNA #sequencing #biomarker

Microfluidics technology is revolutionizing #DrugDiscovery by offering physiologically relevant cell-based models for high-throughput screening. I had the pleasure of talking to Jeff Jensen, CEO of Fluxion Biosciences about the transformative impact of microfluidics on drug discovery and basic research, and the innovative tools Fluxion Biosciences provides to the scientific community. Read the conversation here: https://lnkd.in/e_ZWeex4 #Microfluidics #CARTcelltherapy #IonChannels

Read this nice blog from the Oncode Accelerator team on the network of the Federation of European Biochemical Societies (FEBS), with more detail on the Innovation Platforms and Workstreams within the program and our call for Demonstrator Projects. #FEBS #cancerresearch #drugdevelopment #oncodeaccelerator #biotech https://bit.ly/45F5eaJ

Keeping pace with the rapid development in life science and biotech fields is no easy task. That is why Dimensions launched the Dimensions Biotech Solution this year. Born out of customer needs, Dimensions Biotech Solution is a one-stop-shop that merges 48 million open publications, 93 million closed publications, 158 million patents, 814 thousand clinical trials, and US$2.4 trillion in global funding data into visual and interactive applications for fast interpretation. Check out this blog with inputs from Lauren Black and Michael Torres to see how you can stay ahead of the game in complex, fast-evolving and crucial fields like omics, NGS and Cell&Gene. https://lnkd.in/eUHb3Uk5 #LifeSciences #Biotech #NGS #CellandGene #Omics

Stay Ahead in Cellular Research Unlocking live cell insights and going deeper into real-time cell analysis with the cutting-edge technology offered by xCELLigence Real Time Cell Analyzers. This powerful platform is to monitor cellular behavior, continuously over a certain timespan and non-invasively. ·     Dynamic insights into cytotoxicity, drug responses and cell-cell interactions in real-time. ·     Extraordinary sensitive and label-free analysis for detection of cellular responses to various stimuli are detected with outstanding sensitivity. ·     High-throughput accelerates data generation making xCELLigence an ideal platform for screening assays and drug discovery applications.   Find out more applications:  https://lnkd.in/eTBBzDaN #cellanalysis #drugdiscovery #screening #biotechnology #lifesciences

🔬🧫 Exciting advancements in cell culture! Discover the benefits and challenges of both adherent and suspension platforms. Which one suits your research needs? Dive into the details and make an informed choice! 👉 #CellCulture #Biotech #ResearchInnovation #LabLife

Exciting times in the world of cell programming this week as we welcome GC Therapeutics to our industry. At bit.bio, we've been pioneering transcription factor technology since 2016. It's gratifying to see how the industry has evolved, with brilliant minds like those at GCTx joining the quest to unlock the full potential of cellular reprogramming. This expanding ecosystem is fantastic news for the entire biotech community. It validates the immense promise of our approach and will undoubtedly accelerate innovation in cell therapies and drug discovery. At bit.bio, we're pushing the boundaries of our discovery platform, regularly introducing novel R&D grade cell types that demonstrate the power of TF programming combined with our opti-ox technology. This allows us to achieve unprecedented consistency and scale, potentially reducing the cost of cell therapies by two orders of magnitude. As we move forward, we remain committed to collaboration. The challenges we face in revolutionising medicine are immense, and it will take a collective effort to overcome them. We look forward to seeing how GC Therapeutics and others in our field will contribute to this shared mission. #CellTherapy #CellProgramming #StemCells #StemCell #StemCellTherapy #iPSC #iPSCs #iPSCTherapy #RegenerativeMedicine #Biology #GeneEditing #MachineLearning #Biotech #GCTx #GCTherapeutics #bitbio #TF #TranscriptionFactors

Keeping pace with the rapid development in life science and biotech fields is no easy task. That is why Dimensions launched the Dimensions Biotech Solution this year. Born out of customer needs, Dimensions Biotech Solution is a one-stop-shop that merges 48 million open publications, 93 million closed publications, 158 million patents, 814 thousand clinical trials, and US$2.4 trillion in global funding data into visual and interactive applications for fast interpretation. Check out this blog with inputs from Lauren Black and Michael Torres to see how you can stay ahead of the game in complex, fast-evolving and crucial fields like omics, NGS and Cell&Gene. https://lnkd.in/ezf5Pz25 #LifeSciences #Biotech #NGS #CellandGene #Omics

Keeping pace with the rapid development in life science and biotech fields is no easy task. That is why Dimensions launched the Dimensions Biotech Solution this year. Born out of customer needs, the Dimensions Biotech Solution is a one-stop-shop that merges 48 million open publications, 93 million closed publications, 158 million patents, 814 thousand clinical trials, and US$2.4 trillion in global funding data into visual and interactive applications for fast interpretation. Check out our blog with inputs from Lauren Black and Michael Torres to see how you can stay ahead of the game in complex, fast-evolving and crucial fields like omics, NGS and Cell&Gene. https://ow.ly/faAE50RafBw #LifeSciences #Biotech #NGS #CellandGene #Omics